Просмотр новости
Найдите то, что Вас интересует
Спутники
РН
SpaceX
Роскосмос
NASA
СпутникиРНSpaceXРоскосмосNASANEW YORK (AP) — Popular — and expensive — GLP-1 weight loss drugs just got a lot cheaper for many older Americans. Starting Wednesday, the federal government is offering a selection of the brand name medications to certain Medicare and Medicare Advantage beneficiaries for $50 a month through a new trial called Medicare GLP-1 Bridge. [...]
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Medicare is now covering some GLP-1 weight loss drugs for $50. Here’s what to know | 5 | 5 | 01-07-2026 |
| 2 | GLP-1 use hits record high as Medicare opens access to weight-loss drugs | 0 | 7 | 09-07-2026 |
| 3 | GLP-1 insurance change impacts millions of Americans: What to know, how to tell if you’re covered | 0 | 7 | 18-07-2026 |
| 4 | Novo Nordisk’s obesity drug Wegovy gets CDSCO approval to treat liver condition | 5 | 7 | 17-07-2026 |
| 5 | Women more often hired after losing weight on GLP-1s: Study | 0 | 5 | 03-07-2026 |
| 6 | Medicare prescriptions for Wegovy jumped after approval for heart disease | 0 | 7 | 09-07-2026 |
| 7 | GLP-1 'secret shopper' study finds gaps in online prescribing | 0 | 5 | 07-07-2026 |
| 8 | CMS Proposes Cut To Hospitals' 340B Drug Reimbursements | -2 | 6 | 02-07-2026 |
| 9 | FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients | 5 | 7 | 16-07-2026 |
| 10 | Demand for GLP-1 weight-loss and diabetes drugs plateaus, says industry tracker | 0 | 7 | 08-07-2026 |